Bermuda
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.52 (0.44 - 0.62) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 0.56 (0.47 - 0.65) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.56 (0.47 - 0.65) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.56 (0.48 - 0.64) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.56 (0.48 - 0.65) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.57 (0.49 - 0.65) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.57 (0.49 - 0.65) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.57 (0.49 - 0.65) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.57 (0.49 - 0.65) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.57 (0.49 - 0.66) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.58 (0.49 - 0.66) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.58 (0.50 - 0.67) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.59 (0.50 - 0.68) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.59 (0.50 - 0.69) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.70) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.69) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.69) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.69) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.69) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.49 - 0.70) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.70) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.50 - 0.70) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.6 (0.51 - 0.70) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.56 (0.47 - 0.65) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.24 (0.16 - 0.32) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 0.31 (0.21 - 0.42) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.3 (0.21 - 0.41) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.3 (0.22 - 0.41) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.31 (0.22 - 0.41) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.22 - 0.43) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.23 - 0.43) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.23 - 0.43) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.23 - 0.43) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.23 - 0.43) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.22 - 0.43) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.32 (0.23 - 0.43) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.33 (0.23 - 0.44) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.45) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.45) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.47) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.47) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.24 - 0.46) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.34 (0.23 - 0.46) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Number of persons living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 335 (281 - 394) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 348 (293 - 406) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 348 (294 - 403) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 349 (296 - 404) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 352 (301 - 402) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 355 (304 - 407) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 356 (306 - 408) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 358 (307 - 409) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 359 (309 - 411) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 360 (311 - 413) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 361 (310 - 416) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 363 (311 - 418) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 366 (313 - 422) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 369 (314 - 427) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 372 (314 - 430) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 372 (312 - 434) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 371 (311 - 431) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 370 (310 - 428) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 368 (307 - 426) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 366 (303 - 426) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 364 (299 - 426) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 363 (303 - 422) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 362 (304 - 419) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 361 (303 - 417) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 359 (302 - 414) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 358 (300 - 413) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 355 (299 - 410) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 353 (297 - 408) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 351 (297 - 406) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 348 (294 - 406) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 346 (290 - 404) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 2.36 (1.76 - 3.13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 3.84 (3.01 - 4.82) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.77 (2.95 - 4.72) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.57 (2.79 - 4.44) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.48 (2.72 - 4.35) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.29 (2.55 - 4.10) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.04 (2.37 - 3.79) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.5 (1.95 - 3.14) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.84 (2.21 - 3.57) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.15 (1.66 - 2.74) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.29 (1.78 - 2.91) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.01 (1.54 - 2.59) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.92 (1.48 - 2.46) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.89 (1.47 - 2.42) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.88 (1.45 - 2.43) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.88 (1.47 - 2.46) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.87 (1.46 - 2.42) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.86 (1.45 - 2.42) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.88 (1.46 - 2.43) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.91 (1.48 - 2.47) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.97 (1.52 - 2.54) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.93 (1.50 - 2.49) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.97 (1.54 - 2.54) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.07 (1.61 - 2.65) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.02 (1.57 - 2.58) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.14 (1.64 - 2.76) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.2 (1.67 - 2.84) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.26 (1.70 - 2.95) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.29 (1.70 - 3) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.33 (1.74 - 3.07) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.36 (1.76 - 3.13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.71 (1.38 - 2.13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.7 (1.39 - 2.11) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.68 (1.37 - 2.09) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.65 (1.37 - 2.04) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.34 - 2) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.33 - 1.99) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.33 - 1.99) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.63 (1.33 - 2.02) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.64 (1.34 - 2.03) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.65 (1.34 - 2.05) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.65 (1.35 - 2.05) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.66 (1.35 - 2.05) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.67 (1.36 - 2.05) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.68 (1.37 - 2.06) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.69 (1.38 - 2.07) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.71 (1.39 - 2.10) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.73 (1.41 - 2.13) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.75 (1.42 - 2.17) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.77 (1.43 - 2.18) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.79 (1.45 - 2.20) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.8 (1.46 - 2.21) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.82 (1.48 - 2.24) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.84 (1.49 - 2.28) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.86 (1.50 - 2.30) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.87 (1.52 - 2.30) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.88 (1.52 - 2.33) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.89 (1.53 - 2.34) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.89 (1.54 - 2.36) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.9 (1.54 - 2.37) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.91 (1.55 - 2.39) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.65 (1.33 - 2.06) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Number of persons living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,092 (886 - 1,368) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,097 (892 - 1,368) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,101 (895 - 1,369) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,103 (896 - 1,374) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,105 (897 - 1,370) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,106 (898 - 1,369) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,106 (897 - 1,371) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,103 (896 - 1,362) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,098 (890 - 1,355) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,093 (884 - 1,343) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,088 (879 - 1,338) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,082 (879 - 1,341) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,075 (876 - 1,331) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,068 (869 - 1,318) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,060 (866 - 1,303) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,055 (860 - 1,293) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,051 (858 - 1,291) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,048 (852 - 1,285) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,046 (849 - 1,289) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,043 (851 - 1,290) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,040 (847 - 1,294) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,035 (846 - 1,283) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,028 (843 - 1,272) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,022 (841 - 1,259) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,018 (838 - 1,255) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,021 (841 - 1,254) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,036 (860 - 1,273) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,052 (862 - 1,307) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,059 (869 - 1,313) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,057 (854 - 1,317) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,062 (859 - 1,323) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 2.94 (2.13 - 3.96) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 4.54 (3.55 - 5.72) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.44 (3.47 - 5.62) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.16 (3.23 - 5.28) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.23 (3.30 - 5.37) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.97 (3.08 - 5.03) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.69 (2.88 - 4.66) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.91 (2.27 - 3.73) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.13 (2.43 - 4.01) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.5 (2.71 - 4.45) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.74 (2.15 - 3.55) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.59 (2.01 - 3.36) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.43 (1.88 - 3.16) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.46 (1.90 - 3.20) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.35 (1.81 - 3.05) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.38 (1.84 - 3.10) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.34 (1.80 - 3.08) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.34 (1.80 - 3.05) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.34 (1.80 - 3.07) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.37 (1.82 - 3.09) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.41 (1.86 - 3.19) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.38 (1.84 - 3.12) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.41 (1.86 - 3.18) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.46 (1.89 - 3.25) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.53 (1.95 - 3.33) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.62 (1.98 - 3.44) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.7 (2.02 - 3.57) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.83 (2.07 - 3.75) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.78 (2.06 - 3.68) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.88 (2.10 - 3.82) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.94 (2.13 - 3.96) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
2
2019
(1 - 2)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
2
2019
(1 - 3)
IHME, GBD 2019 (accessed 2020)
Survey/surveillance
No data available
HCV chart
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines